Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Azoxy doai
Patent
1992-08-27
1994-09-27
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Azoxy doai
514278, 514316, 514318, 514337, 514826, 514912, 546 15, 546187, 546193, 546194, 546269, A61K 31655, A61K 3144, C07D40512
Patent
active
053507444
ABSTRACT:
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.
REFERENCES:
patent: 4486445 (1984-12-01), Patel et al.
patent: 4937373 (1990-06-01), Carson et al.
Girard Yves
Hamel Pierre
Ivy C. Warren
Merck Frosst Canada Inc.
Owens A. A.
Rose David L.
Yang Mollie M.
LandOfFree
Phenylnaphthalene lactones as inhibitors of leukotriene biosynth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylnaphthalene lactones as inhibitors of leukotriene biosynth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylnaphthalene lactones as inhibitors of leukotriene biosynth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1265531